Vertex Pharmaceuticals Incorporated
PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
Last updated:
Abstract:
The disclosure provides processes for synthesizing compounds for use as CFTR modulators. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
30 Nov 2018
Issue date:
17 Sep 2020